Last reviewed · How we verify

NCT04471168: AURICULO-DODO

Interest of Auriculotherapy in the Management of Chronic Insomnia

Recruiting now NA Last updated 3 April 2025
What this trial tests

NA trial testing Cryo-Auriculotherapy in Chronic Insomnia in 72 participants. Currently enrolling.

Timeline
14 October 2020
Primary endpoint
14 October 2025
14 October 2025

Quick facts

Lead sponsorHopital Foch
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment72
Start date14 October 2020
Primary completion14 October 2025
Estimated completion14 October 2025
Sites4 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Hopital Foch — full company profile →

Who can join

Adults 18 to 64, any sex, with Chronic Insomnia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to show that auriculotherapy is effective in the treatment of chronic insomnia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Cryo-Auriculotherapy

Trials testing the same drug.

Other recruiting trials for Chronic Insomnia

Currently open trials in the same condition.

Other Hopital Foch trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04471168.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing